Clinical research company IQVIA (NYSE: IQV) reported Q3 CY2025 results , with sales up 5.2% year on year to $4.1 billion. The ...

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

At the 19th Annual Ambulatory Surgery Centers Conference in Chicago, Larry Cohen, MD, and Jordan Fowler, CEO of Frontier Healthcare Management Services, will give a presentation titled “Key Business ...

NeoGenomics reaffirmed its full-year 2025 guidance, projecting revenue between $720 million and $726 million, representing 9-10% growth from fiscal 2024. The company expects a net loss between $108 ...

Longer-Term Follow-Up of Western Patients Showed Improving, Favorable Trend in Overall Survival in Global Phase III HARMONi Clinical Trial for Ivonescimab Plus Chemotherapy in 2L+ EGFRm NSCLC With ...